• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在澳大利亚实施针对中重度膝关节骨关节炎的国家一线管理计划:一项聚焦于避免膝关节置换的预算影响分析。

Implementing a national first-line management program for moderate-severe knee osteoarthritis in Australia: A budget impact analysis focusing on knee replacement avoidance.

作者信息

Ackerman Ilana N, Skou Søren T, Roos Ewa M, Barton Christian J, Kemp Joanne L, Crossley Kay M, Liew Danny, Ademi Zanfina

机构信息

School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Research Unit for Musculoskeletal Function and Physiotherapy, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.

出版信息

Osteoarthr Cartil Open. 2020 May 6;2(3):100070. doi: 10.1016/j.ocarto.2020.100070. eCollection 2020 Sep.

DOI:10.1016/j.ocarto.2020.100070
PMID:36474677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9718332/
Abstract

OBJECTIVE

To model potential cost savings associated with implementing a first-line management program for moderate-severe knee osteoarthritis (OA) at a national level in Australia.

METHODS

A budget impact analysis was undertaken using published trial data and publically available data. Australian population projections and OA prevalence data were used to forecast likely need for total knee replacement (TKR) surgery for 2019-2029. Published data were sourced on TKR avoidance following a 12-week non-surgical knee OA management program (exercise therapy, education, insoles, dietary advice, analgesia) and cost per TKR in Australia. The cost of providing the first-line program was estimated on a sliding scale ($AUD750-$3000), with a base case of $AUD1,500. These inputs were used to model potential annual savings associated with national implementation of the program.

RESULTS

The number of people in Australia with moderate-severe knee OA requiring TKR was estimated to be 56,007 in 2019, rising to 69,038 by 2029. Avoidance of TKR by 34%-68% of people after the first-line management program could translate to savings of $AUD303million-690 million in 2019. Successively lowering the proportion of people who avoided TKR demonstrated that only 1 in 12 program recipients would need to avoid surgery for the program to generate savings.

CONCLUSIONS

National implementation of a first-line OA management program as an alternative to TKR could produce substantial cost savings for the Australian healthcare system. Longer term data on TKR avoidance is needed to establish whether cost savings are realised or simply shifted to later years.

摘要

目的

在澳大利亚全国范围内建立一个与实施中重度膝骨关节炎(OA)一线管理项目相关的潜在成本节约模型。

方法

使用已发表的试验数据和公开可得数据进行预算影响分析。利用澳大利亚人口预测数据和OA患病率数据预测2019 - 2029年全膝关节置换术(TKR)手术的可能需求。获取已发表的关于为期12周的非手术膝骨关节炎管理项目(运动疗法、教育、鞋垫、饮食建议、镇痛)后TKR避免情况的数据以及澳大利亚TKR的每项成本数据。提供一线项目的成本按滑动比例估算(750澳元 - 3000澳元),基础情况为1500澳元。这些输入数据用于建立与该项目在全国实施相关的潜在年度节约成本模型。

结果

估计2019年澳大利亚中重度膝OA需要进行TKR的人数为56,007人,到2029年将增至69,038人。一线管理项目后34% - 68%的人避免进行TKR,这可能在2019年节省3.03亿澳元 - 6.9亿澳元。依次降低避免进行TKR的人群比例表明,该项目每12名接受者中只需有1人避免手术就能实现节约成本。

结论

在全国实施一线OA管理项目以替代TKR可为澳大利亚医疗系统大幅节约成本。需要关于TKR避免情况的长期数据来确定节约成本是否得以实现,还是仅仅转移到了后续年份。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38b6/9718332/de1f0247e7ab/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38b6/9718332/5a8116a2380f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38b6/9718332/de1f0247e7ab/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38b6/9718332/5a8116a2380f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38b6/9718332/de1f0247e7ab/gr2.jpg

相似文献

1
Implementing a national first-line management program for moderate-severe knee osteoarthritis in Australia: A budget impact analysis focusing on knee replacement avoidance.在澳大利亚实施针对中重度膝关节骨关节炎的国家一线管理计划:一项聚焦于避免膝关节置换的预算影响分析。
Osteoarthr Cartil Open. 2020 May 6;2(3):100070. doi: 10.1016/j.ocarto.2020.100070. eCollection 2020 Sep.
2
The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030.预计到 2030 年,澳大利亚原发性全膝关节和髋关节置换术治疗骨关节炎的负担。
BMC Musculoskelet Disord. 2019 Feb 23;20(1):90. doi: 10.1186/s12891-019-2411-9.
3
Cost-effectiveness of total knee replacement in addition to non-surgical treatment: a 2-year outcome from a randomised trial in secondary care in Denmark.全膝关节置换术联合非手术治疗的成本效益:丹麦二级保健中一项随机试验的 2 年结果。
BMJ Open. 2020 Jan 15;10(1):e033495. doi: 10.1136/bmjopen-2019-033495.
4
Total knee replacement and non-surgical treatment of knee osteoarthritis: 2-year outcome from two parallel randomized controlled trials.全膝关节置换与膝关节骨关节炎非手术治疗的 2 年随机对照研究结果。
Osteoarthritis Cartilage. 2018 Sep;26(9):1170-1180. doi: 10.1016/j.joca.2018.04.014. Epub 2018 May 1.
5
6
The cost utility of autologous chondrocytes implantation using ChondroCelect® in symptomatic knee cartilage lesions in Belgium.在比利时,使用 ChondroCelect® 进行自体软骨细胞移植治疗症状性膝关节软骨损伤的成本效用分析。
Pharmacoeconomics. 2010;28(12):1129-46. doi: 10.2165/11584920-000000000-00000.
7
Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain.利伐沙班对西班牙髋或膝关节置换术后血栓栓塞事件预防的预算影响
J Health Econ Outcomes Res. 2016 Jan 28;4(1):35-46. doi: 10.36469/9824. eCollection 2016.
8
Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.使用透明质酸钠凝胶20进行膝关节腔内粘弹性补充治疗骨关节炎:一项循证分析。
Ont Health Technol Assess Ser. 2005;5(10):1-66. Epub 2005 Jun 1.
9
Cost utility modeling of early vs late total knee replacement in osteoarthritis patients.骨关节炎患者早期与晚期全膝关节置换的成本效用模型
Osteoarthritis Cartilage. 2016 Dec;24(12):2069-2076. doi: 10.1016/j.joca.2016.07.013. Epub 2016 Aug 1.
10
Cost-effectiveness of 12 weeks of supervised treatment compared to written advice in patients with knee osteoarthritis: a secondary analysis of the 2-year outcome from a randomized trial.膝关节骨关节炎患者 12 周监督治疗与书面建议的成本效益比较:一项随机试验 2 年结局的二次分析。
Osteoarthritis Cartilage. 2020 Jul;28(7):907-916. doi: 10.1016/j.joca.2020.03.009. Epub 2020 Mar 31.

引用本文的文献

1
Estimating Budget Impact and Joint Replacement Avoidance by Implementing a Standardized Education and Exercise Therapy Program for Hip and Knee Osteoarthritis in a Publicly Insured Health Care System.在一个公共保险的医疗保健系统中,通过实施针对髋膝关节骨关节炎的标准化教育和运动疗法计划来评估预算影响和避免关节置换
Arthritis Care Res (Hoboken). 2025 Jun;77(6):744-752. doi: 10.1002/acr.25492. Epub 2025 Feb 6.
2
General practitioners experience multi-level barriers to implementing recommended care for hip and knee osteoarthritis: a qualitative study.全科医生在实施髋膝关节骨关节炎推荐治疗方面面临多层次障碍:一项定性研究。
BMC Prim Care. 2024 Dec 19;25(1):423. doi: 10.1186/s12875-024-02658-0.
3

本文引用的文献

1
Cost-effectiveness of total knee replacement in addition to non-surgical treatment: a 2-year outcome from a randomised trial in secondary care in Denmark.全膝关节置换术联合非手术治疗的成本效益:丹麦二级保健中一项随机试验的 2 年结果。
BMJ Open. 2020 Jan 15;10(1):e033495. doi: 10.1136/bmjopen-2019-033495.
2
Patients' experiences of discontentment one year after total knee arthroplasty- a qualitative study.患者在全膝关节置换术后一年的不满体验——一项定性研究。
BMC Musculoskelet Disord. 2020 Jan 14;21(1):29. doi: 10.1186/s12891-020-3041-y.
3
The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030.
Literature Review to Understand the Burden and Current Non-surgical Management of Moderate-Severe Pain Associated with Knee Osteoarthritis.
文献综述:了解与膝关节骨关节炎相关的中重度疼痛的负担及当前非手术治疗方法
Rheumatol Ther. 2024 Dec;11(6):1457-1499. doi: 10.1007/s40744-024-00720-y. Epub 2024 Oct 30.
4
Lifetime Cost-Effectiveness of Structured Education and Exercise Therapy for Knee Osteoarthritis in Australia.澳大利亚膝关节骨关节炎的结构化教育和运动疗法的终生成本效益。
JAMA Netw Open. 2024 Oct 1;7(10):e2436715. doi: 10.1001/jamanetworkopen.2024.36715.
5
Net cost savings arising from patient completion of an active self-management program.患者完成主动自我管理项目所产生的净成本节约。
PLoS One. 2023 Nov 15;18(11):e0293352. doi: 10.1371/journal.pone.0293352. eCollection 2023.
6
Do people with knee osteoarthritis use guideline-consistent treatments after an orthopaedic surgeon recommends nonsurgical care? A cross-sectional survey with long-term follow-up.在骨科医生建议非手术治疗后,膝骨关节炎患者是否采用符合指南的治疗方法?一项具有长期随访的横断面调查。
Osteoarthr Cartil Open. 2022 Mar 28;4(2):100256. doi: 10.1016/j.ocarto.2022.100256. eCollection 2022 Jun.
7
Developing and internally validating a prediction model for total knee replacement surgery in patients with osteoarthritis.开发并在内部验证骨关节炎患者全膝关节置换手术的预测模型。
Osteoarthr Cartil Open. 2022 May 28;4(3):100281. doi: 10.1016/j.ocarto.2022.100281. eCollection 2022 Sep.
8
Barriers and enablers to uptake of a contemporary guideline-based management program for hip and knee osteoarthritis: A qualitative study.基于当代指南的髋膝关节骨关节炎管理项目采用的障碍与促进因素:一项定性研究
Osteoarthr Cartil Open. 2020 Aug 26;2(4):100095. doi: 10.1016/j.ocarto.2020.100095. eCollection 2020 Dec.
9
Program evaluation of GLA:D® Australia: Physiotherapist training outcomes and effectiveness of implementation for people with knee osteoarthritis.澳大利亚GLA:D®项目评估:物理治疗师培训成果及对膝骨关节炎患者的实施效果
Osteoarthr Cartil Open. 2021 May 13;3(3):100175. doi: 10.1016/j.ocarto.2021.100175. eCollection 2021 Sep.
10
Implementation of clinical guidelines for osteoarthritis together (IMPACT): protocol for a participatory health research approach to implementing high value care.临床骨关节炎指南实施研究(IMPACT):实施高价值医疗保健的参与式健康研究方法的方案。
BMC Musculoskelet Disord. 2022 Jul 5;23(1):643. doi: 10.1186/s12891-022-05599-w.
预计到 2030 年,澳大利亚原发性全膝关节和髋关节置换术治疗骨关节炎的负担。
BMC Musculoskelet Disord. 2019 Feb 23;20(1):90. doi: 10.1186/s12891-019-2411-9.
4
How long does a knee replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up.人工膝关节置换的使用寿命有多长?一项超过 15 年随访的病例系列和国家登记报告的系统评价和荟萃分析。
Lancet. 2019 Feb 16;393(10172):655-663. doi: 10.1016/S0140-6736(18)32531-5. Epub 2019 Feb 14.
5
Lifetime risk of primary total knee replacement surgery in New Zealand from 2000 to 2015.2000年至2015年新西兰初次全膝关节置换手术的终身风险。
N Z Med J. 2019 Feb 1;132(1489):48-56.
6
Incremental clinical effectiveness and cost effectiveness of providing supervised physiotherapy in addition to usual medical care in patients with osteoarthritis of the hip or knee: 2-year results of the MOA randomised controlled trial.在常规医疗基础上增加监督下的物理治疗对髋或膝关节骨关节炎患者的临床效果和成本效果的逐步增加:MOA 随机对照试验的 2 年结果。
Osteoarthritis Cartilage. 2019 Mar;27(3):424-434. doi: 10.1016/j.joca.2018.12.004. Epub 2018 Dec 14.
7
Revisiting patient satisfaction following total knee arthroplasty: a longitudinal observational study.全膝关节置换术后患者满意度再探讨:一项纵向观察性研究。
BMC Musculoskelet Disord. 2018 Nov 30;19(1):423. doi: 10.1186/s12891-018-2340-z.
8
Knee replacement.膝关节置换术。
Lancet. 2018 Nov 3;392(10158):1672-1682. doi: 10.1016/S0140-6736(18)32344-4.
9
Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment.髋部和/或膝部骨关节炎的结构化教育与神经肌肉锻炼计划:一项卫生技术评估
Ont Health Technol Assess Ser. 2018 Nov 2;18(8):1-110. eCollection 2018.
10
Cost-Effectiveness of Diet and Exercise for Overweight and Obese Patients With Knee Osteoarthritis.饮食和运动干预超重和肥胖膝骨关节炎患者的成本效果分析。
Arthritis Care Res (Hoboken). 2019 Jul;71(7):855-864. doi: 10.1002/acr.23716.